TBA
Oliver K Valet
rap.ID Inc., Germany
: J Pharm Drug Deliv Res
Abstract
The attention on foreign particulate contamination on parenteral drug products is strongly growing as shown by more than 8 voluntary product recalls in the last 60 days alone. Besides the loss of product, the impact on reputation can generate immense losses. Root cause investigation by means of Raman, LIBS, EDS and IR-Spectroscopy, sampling strategies, and comparisons of the particle materials with sources from manufacturing or packaging will be covered in the training as well. Documentation is an integral part of the control of foreign particulate matter, so you will also learn the proper documentation and interpretation of foreign particulate matter.
Biography
Oliver Valet is one of the co-founders of rap.ID Particle Systems GmbH a company that develops manufactures and sells rapid particle identification systems. Within rap.ID, he is responsible for the product development and their worldwide marketing and sales. From the contract testing work performed at both rap.ID sites in Berlin and Princeton New Jersey, he has more than a decade experience in the field of industrial and environmental chemical analysis on particles. As an active member of the Respiratory Drug Delivery, RDD, the Royal Chemical Society, Parenteral Drug Association, PDA and American Association of Pharmaceutical Science, AAPS and the Apotekerverband, APV he has published his work continuously and presented in various conferences.
oliver.valet@rapid.com
